These success, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 assist the principle of targeting ACKR3 as a unique approach to modulate the opioid process, which could open up new therapeutic avenues for opioid-similar disorders. The location is protected. The https://willaf406fvg5.topbloghub.com/profile